Skip to content

ASSESSMENT OF EFFECTIVENESS OF PERUNGAYA CHOORANAM IN TREATING SOOTHAGA SOOLAI DUE TO ENDOMETRIOSIS For 20 Participants in GSMC, PALAYAMKOTTAI.

ASSESSMENT OF EFFECTIVENESS OF PERUNGAYA CHOORANAM IN TREATING SOOTHAGA SOOLAI DUE TO ENDOMETRIOSIS AMONG PATIENTS ATTENDING OPD,GOVERNMENT SIDDHA MEDICAL COLLEGE AND HOSPITAL PALAYAMKOTTAI - A CASE SERIES - NIL

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2025/08/092757
Enrollment
20
Registered
2025-08-11
Start date
Unknown
Completion date
Unknown
Last updated
2025-08-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: N809- Endometriosis, unspecified

Interventions

Intervention1: PERUNGAYA CHOORANAM: PERUNGAYA CHOORANAM 800-1000mg,twice daily with hot water as internal medicine for a period of 90 days Control Intervention1: Nil: Nil

Sponsors

DR SRINIJA E
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patients with Dysmenorrhea,Chronic Pelvic Pain, Dyspareunia, Abnormal/Irregular uterine bleeding, Genitourinary symptoms, Gastrointestinal symptoms, Premenstrual dysphoric disorder, acne, Insomnia,Fatigue,headache.

Exclusion criteria

Exclusion criteria: Pregnancy & lactating women,History of suspicion of hormone dependent tumor, Bilateral salpingo-oophorectomy.

Design outcomes

Primary

MeasureTime frame
The study will reveal the efficacy of Perungaya Chooranam in treating Soothaga Soolai.Timepoint: 90 days

Secondary

MeasureTime frame
Improvement of patients will be assessed by laboratory investigation (Before & After treatment) and symptoms will be analysed (Before & After treatment)Timepoint: 90 days

Countries

India

Contacts

Public ContactDRV MURUGANMDSIDDHA

GOVERNMENT SIDDHA MEDICAL COLLEGE AND HOSPITAL PALAYAMKOTTAI, TIRUNELVELI-627002

dr.murugu23@gmail.com9488669913

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026